多发性骨髓瘤老年患者可能用药不当的相关因素。

IF 1 4区 医学 Q4 ONCOLOGY Journal of Oncology Pharmacy Practice Pub Date : 2024-07-01 Epub Date: 2023-08-01 DOI:10.1177/10781552231190009
Taisa R L Machado, Cristiane A M de Pádua, Paula L de Miranda Drummond, Lívia P Silveira, Jéssica S Malta, Roberta M M Dos Santos, Naiane L Costa, Adriano M M Reis
{"title":"多发性骨髓瘤老年患者可能用药不当的相关因素。","authors":"Taisa R L Machado, Cristiane A M de Pádua, Paula L de Miranda Drummond, Lívia P Silveira, Jéssica S Malta, Roberta M M Dos Santos, Naiane L Costa, Adriano M M Reis","doi":"10.1177/10781552231190009","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Elderly with cancer often have multimorbidity, which determines a higher risk of polypharmacy. This is related to negative clinical results such as adverse drug reaction and emergence service visits. Furthermore, polypharmacy increases the risk of using potentially inappropriate medications.</p><p><strong>Objective: </strong>To evaluate the use of potentially inappropriate medication in elderly with multiple myeloma and associated factors.</p><p><strong>Methods: </strong>The study was conducted with older adults with multiple myeloma treated at outpatient oncology and hematology services in a southeastern Brazilian capital. Potentially inappropriate medications were classified using the American Geriatric Society/Beers 2019 Criteria. Variables were described using frequency and proportions, performing multiple logistic regression to identify factors associated with the use of potentially inappropriate medications.</p><p><strong>Results: </strong>One hundred fifty-three older adults with multiple myeloma were included, with a median age of 70.9 years. The median number of medications was 8, and 63% of patients used polypharmacy. More than half (54%) of the patients used potentially inappropriate medications, and proton pump inhibitors (46%) and benzodiazepines (8%) were the most employed therapeutic classes. Older adults who used potentially inappropriate medications differed from those who did not use them in the following characteristics: income up to three minimum wages, higher schooling level, private service, multimorbidity, hypertension, cardiovascular disease, chronic kidney disease, depression, adverse event, and polypharmacy. Higher schooling levels and polypharmacy were independently associated with the use of potentially inappropriate medications in the multivariate analysis.</p><p><strong>Conclusion: </strong>Potentially inappropriate medication use was high in patients with multiple myeloma studied. The use of polypharmacy and higher schooling levels were independently and positively associated with the use of potentially inappropriate medications.</p>","PeriodicalId":16637,"journal":{"name":"Journal of Oncology Pharmacy Practice","volume":null,"pages":null},"PeriodicalIF":1.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Factors associated with potentially inappropriate medications in elderly with multiple myeloma.\",\"authors\":\"Taisa R L Machado, Cristiane A M de Pádua, Paula L de Miranda Drummond, Lívia P Silveira, Jéssica S Malta, Roberta M M Dos Santos, Naiane L Costa, Adriano M M Reis\",\"doi\":\"10.1177/10781552231190009\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Elderly with cancer often have multimorbidity, which determines a higher risk of polypharmacy. This is related to negative clinical results such as adverse drug reaction and emergence service visits. Furthermore, polypharmacy increases the risk of using potentially inappropriate medications.</p><p><strong>Objective: </strong>To evaluate the use of potentially inappropriate medication in elderly with multiple myeloma and associated factors.</p><p><strong>Methods: </strong>The study was conducted with older adults with multiple myeloma treated at outpatient oncology and hematology services in a southeastern Brazilian capital. Potentially inappropriate medications were classified using the American Geriatric Society/Beers 2019 Criteria. Variables were described using frequency and proportions, performing multiple logistic regression to identify factors associated with the use of potentially inappropriate medications.</p><p><strong>Results: </strong>One hundred fifty-three older adults with multiple myeloma were included, with a median age of 70.9 years. The median number of medications was 8, and 63% of patients used polypharmacy. More than half (54%) of the patients used potentially inappropriate medications, and proton pump inhibitors (46%) and benzodiazepines (8%) were the most employed therapeutic classes. Older adults who used potentially inappropriate medications differed from those who did not use them in the following characteristics: income up to three minimum wages, higher schooling level, private service, multimorbidity, hypertension, cardiovascular disease, chronic kidney disease, depression, adverse event, and polypharmacy. Higher schooling levels and polypharmacy were independently associated with the use of potentially inappropriate medications in the multivariate analysis.</p><p><strong>Conclusion: </strong>Potentially inappropriate medication use was high in patients with multiple myeloma studied. The use of polypharmacy and higher schooling levels were independently and positively associated with the use of potentially inappropriate medications.</p>\",\"PeriodicalId\":16637,\"journal\":{\"name\":\"Journal of Oncology Pharmacy Practice\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Oncology Pharmacy Practice\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/10781552231190009\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/8/1 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Oncology Pharmacy Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/10781552231190009","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/8/1 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

导言患有癌症的老年人通常患有多种疾病,这决定了他们使用多种药物的风险较高。这与不良药物反应和紧急就诊等负面临床结果有关。此外,多重用药还会增加使用潜在不当药物的风险:评估多发性骨髓瘤老年患者使用潜在不当药物的情况及相关因素:研究对象是在巴西东南部首府接受门诊肿瘤学和血液学治疗的多发性骨髓瘤老年人。采用美国老年医学会/比尔斯 2019 年标准对潜在的不适当药物进行分类。使用频率和比例对变量进行描述,并进行多元逻辑回归,以确定与使用潜在不适当药物相关的因素:共纳入153名患有多发性骨髓瘤的老年人,中位年龄为70.9岁。药物中位数为 8 种,63% 的患者使用多种药物。半数以上(54%)的患者使用了可能不适当的药物,质子泵抑制剂(46%)和苯二氮卓类药物(8%)是使用最多的治疗类别。使用潜在不当药物的老年人与未使用药物的老年人在以下特征上存在差异:收入不超过三份最低工资、受教育程度较高、私人服务、多病共患、高血压、心血管疾病、慢性肾病、抑郁、不良事件和多种药物。在多变量分析中,较高的教育水平和多重用药与使用潜在的不适当药物独立相关:结论:在所研究的多发性骨髓瘤患者中,潜在的不适当药物使用率很高。结论:在所研究的多发性骨髓瘤患者中,潜在用药不当的比例较高,而使用多种药物和受教育程度较高与潜在用药不当呈正相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Factors associated with potentially inappropriate medications in elderly with multiple myeloma.

Introduction: Elderly with cancer often have multimorbidity, which determines a higher risk of polypharmacy. This is related to negative clinical results such as adverse drug reaction and emergence service visits. Furthermore, polypharmacy increases the risk of using potentially inappropriate medications.

Objective: To evaluate the use of potentially inappropriate medication in elderly with multiple myeloma and associated factors.

Methods: The study was conducted with older adults with multiple myeloma treated at outpatient oncology and hematology services in a southeastern Brazilian capital. Potentially inappropriate medications were classified using the American Geriatric Society/Beers 2019 Criteria. Variables were described using frequency and proportions, performing multiple logistic regression to identify factors associated with the use of potentially inappropriate medications.

Results: One hundred fifty-three older adults with multiple myeloma were included, with a median age of 70.9 years. The median number of medications was 8, and 63% of patients used polypharmacy. More than half (54%) of the patients used potentially inappropriate medications, and proton pump inhibitors (46%) and benzodiazepines (8%) were the most employed therapeutic classes. Older adults who used potentially inappropriate medications differed from those who did not use them in the following characteristics: income up to three minimum wages, higher schooling level, private service, multimorbidity, hypertension, cardiovascular disease, chronic kidney disease, depression, adverse event, and polypharmacy. Higher schooling levels and polypharmacy were independently associated with the use of potentially inappropriate medications in the multivariate analysis.

Conclusion: Potentially inappropriate medication use was high in patients with multiple myeloma studied. The use of polypharmacy and higher schooling levels were independently and positively associated with the use of potentially inappropriate medications.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.70
自引率
7.70%
发文量
276
期刊介绍: Journal of Oncology Pharmacy Practice is a peer-reviewed scholarly journal dedicated to educating health professionals about providing pharmaceutical care to patients with cancer. It is the official publication of the International Society for Oncology Pharmacy Practitioners (ISOPP). Publishing pertinent case reports and consensus guidelines...
期刊最新文献
Recurrent, multisystem angioedema induced by 5-azacitidine. Exclusion of ranitidine from premedication regimen during paclitaxel treatment: A retrospective single-center analysis. Investigation of 5-fluorouracil cardiotoxicity in combinational therapy: Influence of risk factors and demographics in a Pakistani population. Drug induced lupus associated with Trastuzumab emtansine in a patient with metastatic breast cancer. Identifying risk factors of dose reduction or treatment discontinuation due to fatigue or gastrointestinal symptoms in patients receiving lenvatinib treatment for hepatocellular carcinoma.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1